跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
YESINTEK 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
YESINTEK 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
YESINTEK 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Biosimilar Collaborations Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 20, 2025
Approval ID
e73bcba6e069b71b
Company
Biosimilar Collaborations Ireland Limited
Type
Standard
Approval Details
Approval Id
e73bcba6e069b71b
Drug Cima Aemps Name
YESINTEK 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1241892002
Holder Company Name
Biosimilar Collaborations Ireland Limited
Marketing Company Name
Biocon Biologics Spain, S.L.
Holder Company Detail Path
/organization/biosimilar-collaborations-ireland-ltd
Authorization Date
2025-03-20
Dosage Form
SOLUCIÓN INYECTABLE
Dose
45 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Biosimilar Collaborations Ireland Limited
Company Detail Path
/organization/biosimilar-collaborations-ireland-ltd
Company Information
Pharmaceutical Company Name
Biosimilar Collaborations Ireland Ltd.
Country Name
Ireland
Active Ingredients
USTEKINUMAB
45 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 20, 2025
Approval ID
e73bcba6e069b71b
Type
Standard
Back to CIMA-AEMPS Approvals